Jeff practices corporate and securities law, representing both public and private venture-backed companies. He has deep experience advising life science and technology companies in a variety of transactions, including IPOs and other public offerings, venture financings, mergers and acquisitions, and strategic collaboration and licensing transactions. He also has expertise in SEC reporting and corporate governance matters. 

Jeff’s representation of public companies includes Anterix, Natera, Tricida, MediciNova, Boingo Wireless, Organovo and Pure Biosciences. He also represented CareFusion until its sale to BD for $12.2 billion, Life Technologies until its sale to Thermo Fisher for  $13.6 billion, P.F. Chang’s until its sale for $1.1 billion, and The Active Networks until its sale for $1.0 billion.